Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oleg Butovsky

Showing results (11-20 of 91) with videos related to

Pageof 10
Sort By:
Trends in Neurosciences|January 13, 2006
Microglial phenotype: is the commitment reversible?Michal Schwartz, Oleg Butovsky, Wolfgang Brück, et al.
Molecular and Cellular Neurosciences|June 15, 2007
Microglia can be induced by IFN-gamma or IL-4 to express neural or dendritic-like markersOleg Butovsky, Shay Bukshpan, Gilad Kunis, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|October 25, 2017
Differential contribution of microglia and monocytes in neurodegenerative diseasesCaroline Baufeld, Elaine O'Loughlin, Narghes Calcagno, et al.
Molecular and Cellular Neurosciences|May 14, 2005
Activation of microglia by aggregated beta-amyloid or lipopolysaccharide impairs MHC-II expression and renders them cytotoxic whereas IFN-gamma and IL-4 render them protectiveOleg Butovsky, Adolfo E Talpalar, Keren Ben-Yaakov, et al.
Current Eye Research|December 17, 2008
Weekly vaccination with Copaxone (glatiramer acetate) as a potential therapy for dry age-related macular degenerationGennady Landa, Oleg Butovsky, Johai Shoshani, et al.
European Journal of Immunology|November 19, 2004
Vaccination with autoantigen protects against aggregated beta-amyloid and glutamate toxicity by controlling microglia: effect of CD4+CD25+ T cellsHila Avidan, Jonathan Kipnis, Oleg Butovsky, et al.
Glia|April 8, 2015
Identification of a chronic non-neurodegenerative microglia activation state in a mouse model of peroxisomal β-oxidation deficiencySimon Verheijden, Lien Beckers, Andrea Casazza, et al.
Brain : a Journal of Neurology|May 26, 2017
Loss of 'homeostatic' microglia and patterns of their activation in active multiple sclerosisTobias Zrzavy, Simon Hametner, Isabella Wimmer, et al.
Microbiome|March 11, 2022
The microbiota restrains neurodegenerative microglia in a model of amyotrophic lateral sclerosisLaura M Cox, Narghes Calcagno, Christian Gauthier, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 26, 2006
Glatiramer acetate fights against Alzheimer's disease by inducing dendritic-like microglia expressing insulin-like growth factor 1Oleg Butovsky, Maya Koronyo-Hamaoui, Gilad Kunis, et al.
Pageof 10

Showing results (11-20 of 91) with videos related to

Sort By:
Pageof 10
Trends in Neurosciences|January 13, 2006
Microglial phenotype: is the commitment reversible?Michal Schwartz, Oleg Butovsky, Wolfgang Brück, et al.
Molecular and Cellular Neurosciences|June 15, 2007
Microglia can be induced by IFN-gamma or IL-4 to express neural or dendritic-like markersOleg Butovsky, Shay Bukshpan, Gilad Kunis, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|October 25, 2017
Differential contribution of microglia and monocytes in neurodegenerative diseasesCaroline Baufeld, Elaine O'Loughlin, Narghes Calcagno, et al.
Molecular and Cellular Neurosciences|May 14, 2005
Activation of microglia by aggregated beta-amyloid or lipopolysaccharide impairs MHC-II expression and renders them cytotoxic whereas IFN-gamma and IL-4 render them protectiveOleg Butovsky, Adolfo E Talpalar, Keren Ben-Yaakov, et al.
Current Eye Research|December 17, 2008
Weekly vaccination with Copaxone (glatiramer acetate) as a potential therapy for dry age-related macular degenerationGennady Landa, Oleg Butovsky, Johai Shoshani, et al.
European Journal of Immunology|November 19, 2004
Vaccination with autoantigen protects against aggregated beta-amyloid and glutamate toxicity by controlling microglia: effect of CD4+CD25+ T cellsHila Avidan, Jonathan Kipnis, Oleg Butovsky, et al.
Glia|April 8, 2015
Identification of a chronic non-neurodegenerative microglia activation state in a mouse model of peroxisomal β-oxidation deficiencySimon Verheijden, Lien Beckers, Andrea Casazza, et al.
Brain : a Journal of Neurology|May 26, 2017
Loss of 'homeostatic' microglia and patterns of their activation in active multiple sclerosisTobias Zrzavy, Simon Hametner, Isabella Wimmer, et al.
Microbiome|March 11, 2022
The microbiota restrains neurodegenerative microglia in a model of amyotrophic lateral sclerosisLaura M Cox, Narghes Calcagno, Christian Gauthier, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 26, 2006
Glatiramer acetate fights against Alzheimer's disease by inducing dendritic-like microglia expressing insulin-like growth factor 1Oleg Butovsky, Maya Koronyo-Hamaoui, Gilad Kunis, et al.
Pageof 10